We also found that the HIS subtype had the highest expression of several immune checkpoints (particularly IDO1, CD274 and PDCD1LG2), it means that glioma samples from HIS subtype tend to be immunosuppressed (Figure 3E). This evidence concerns the gene IDO1 and central nervous system cancer.